The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

BPDCN typically presents skin lesions and may also involve bone marrow ... blastic NK cell lymphoma and CD4+/CD56+ hematodermic neoplasm. Capillary leak syndrome (CLS), including life-threatening ...

BPDCN typically presents skin lesions and may also involve bone marrow ... previous names included blastic NK cell lymphoma and CD4+/CD56+ hematodermic neoplasm. Capillary leak syndrome (CLS), ...

The project includes leveraging actual images of BPDCN skin lesions and AI/ML technologies incorporated into the VisualDx platform. The AI model is now live within VisualDx. Menarini Industrie ...

There was evidence of a smooth periosteal reaction associated with the cranial and caudal cortex of the proximal humerus of ...

Clinical evaluation of the degree of neoplastic-disease activity was made ... soft-tissue plasmacytomas, osteolytic lesions and bone-marrow plasmacytosis). 7 The disease was classified as in ...